l-Buthionine Sulfoximine Detection and Quantification in Polyurea Dendrimer Nanoformulations

l-Buthionine sulfoximine (l-BSO) is an adjuvant drug that is reported to increase the sensitivity of cancer cells to neoplastic agents. Dendrimers are exceptional drug delivery systems and l-BSO nanoformulations are envisaged as potential chemotherapeutics. The absorption of l-BSO at a low wavelengt...

Descripción completa

Detalles Bibliográficos
Autores principales: Mota, Pedro, Pires, Rita F., Serpa, Jacinta, Bonifácio, Vasco D. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749587/
https://www.ncbi.nlm.nih.gov/pubmed/31461931
http://dx.doi.org/10.3390/molecules24173111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749587/
https://www.ncbi.nlm.nih.gov/pubmed/31461931
http://dx.doi.org/10.3390/molecules24173111

Ejemplares similares